Novo Nordisk, ING, Shell: European Stocks in the Spotlight
↘️ **Novo Nordisk (DK: NOVO.B**, **NVO)**: Europe's most valuable company raised its annual guidance to reflect better pricing in the U.S., and surging demand for its obesity and weight-loss drugs. Novo expects Wegovy supply constraints to continue, as it grapples to meet demand.